Zhejiang Starry Pharmaceutical Co (SHSE:603520) Cyclically Adjusted Book per Share: ¥4.71 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603520 Zhejiang Starry Pharmaceutical Co Ltd SHSE:603520
76 GF Score
Price ¥8.35
GF Value ¥9.25
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Zhejiang Starry Pharmaceutical Co Cyclically Adjusted Book per Share?

Zhejiang Starry Pharmaceutical Co SHSE:603520 +1.09% 76 Cyclically Adjusted Book per Share is ¥4.71 as of Jun. 2026. GuruFocus rates SHSE:603520 with a GF Score™ of 76/100 and a GF Value™ of ¥9.25 (Modestly Undervalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhejiang Starry Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥5.665. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥4.71 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Zhejiang Starry Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-16), Zhejiang Starry Pharmaceutical Co's current stock price is ¥8.35. Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥4.71. Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.77.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Starry Pharmaceutical Co was 3.66. The lowest was 1.73. And the median was 2.35.


Zhejiang Starry Pharmaceutical Co  (SHSE:603520) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.35/4.706
=1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Starry Pharmaceutical Co was 3.66. The lowest was 1.73. And the median was 2.35.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhejiang Starry Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zhejiang Starry Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Starry Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zhejiang Starry Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 3.39 3.76 4.21 4.67

Zhejiang Starry Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.21 4.23 4.55 4.64 4.71

SHSE:603520 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Starry Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:603520
76GF Score
Zhejiang Starry Pharmaceutical Co Ltd SHSE:603520
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Starry Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Starry Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.665/116.0564*116.0564
=5.665

Current CPI (Jun. 2026) = 116.0564.

Zhejiang Starry Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.474 102.400 2.804
201612 2.512 102.600 2.841
201703 2.598 103.200 2.922
201706 2.567 103.100 2.890
201709 2.615 104.100 2.915
201712 2.650 104.500 2.943
201803 2.716 105.300 2.993
201806 2.664 104.900 2.947
201809 2.723 106.600 2.965
201812 2.803 106.500 3.055
201903 2.911 107.700 3.137
201906 2.970 107.700 3.200
201909 3.117 109.800 3.295
201912 3.131 111.200 3.268
202003 3.285 112.300 3.395
202006 3.359 110.400 3.531
202009 5.354 111.700 5.563
202012 5.453 111.500 5.676
202103 5.692 112.662 5.864
202106 5.878 111.769 6.103
202109 6.062 112.215 6.269
202112 6.476 113.108 6.645
202203 6.671 114.335 6.771
202206 5.531 114.558 5.603
202209 5.432 115.339 5.466
202212 5.165 115.116 5.207
202303 5.203 115.116 5.246
202306 5.116 114.558 5.183
202309 5.151 115.339 5.183
202312 5.135 114.781 5.192
202403 5.171 115.227 5.208
202406 6.179 114.781 6.248
202409 6.097 115.785 6.111
202412 6.009 114.893 6.070
202503 6.043 115.116 6.092
202506 6.005 114.907 6.065
202509 5.947 115.471 5.977
202512 5.849 115.832 5.860
202603 5.888 116.303 5.876
202606 5.665 116.056 5.665

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥4.71 mean?
Zhejiang Starry Pharmaceutical Co (SHSE:603520) has a Cyclically Adjusted Book per Share of ¥4.71 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Starry Pharmaceutical Co and its competitors.
Is Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zhejiang Starry Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.71. Overall, Zhejiang Starry Pharmaceutical Co has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Zhejiang Starry Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥4.71 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Starry Pharmaceutical Co and its competitors. Zhejiang Starry Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Starry Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Starry Pharmaceutical Co (SHSE:603520) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥9.25, compared to a current price of ¥8.35 — trading 9.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥4.71. Zhejiang Starry Pharmaceutical Co's overall GF Score™ is 76/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhejiang Starry Pharmaceutical Co (SHSE:603520), the current Cyclically Adjusted Book per Share is ¥4.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Starry Pharmaceutical Co (SHSE:603520) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Starry Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.35 is trading 9.7% below its estimated GF Value™ of ¥9.25. GuruFocus considers Zhejiang Starry Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603520:

  • Cyclically Adjusted Book per Share: ¥4.71
  • GF Value™: ¥9.25 vs. price of ¥8.35 (9.7% below fair value)
  • GF Score™: 76/100 with 10 warning signs

No single metric tells the full story. See the SHSE:603520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Starry Pharmaceutical Co Business Description

Address No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
76GF Score

Get the complete analysis for SHSE:603520

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.35
Price
¥9.25
GF Value